current single clinical trial is planned to evaluation of effect of lycopene on salivary antioxidant system in cell phone users.30 patients who consulting Zahedan dentistry collage and use cell phone more than 5 years and more than 20 minutes daily,will be chosen voluntary.patients shouldn't eat or drink for 1 hour and then collect their salivary with spitting method.asking them to save salivary in 2 minutes,then centrifugus(2500 cycle per minute) them for 10 minutes that debries take apart.pure salivary sample will be stored in -70 c.volunteers should use 1 lycopene tablet(15mg) vitabiobicts' product daily for 1 month and after 1 month we should sampling again.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT201703043133N10
Registration date:2017-06-06, 1396/03/16
Registration timing:registered_while_recruiting
Last update:
Update count:0
Registration date
2017-06-06, 1396/03/16
Registrant information
Name
Fateme Arbabi Kalati
Name of organization / entity
Dental school of Zahedan
Country
Iran (Islamic Republic of)
Phone
+98 54 1244 1814
Email address
farbabi@razi.tums.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice chancellor for research of Zahedan University of Medical Sciences
Expected recruitment start date
2017-04-04, 1396/01/15
Expected recruitment end date
2017-09-06, 1396/06/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evalouation of the effect of lycopene on salivary antioxidant system in cell phone users
Public title
Evalouation of the effect of lycopene on saliva in cell phone users
Purpose
Diagnostic
Inclusion/Exclusion criteria
Inclusion criteria:users of cell phone at least for 5 years;more than 20 minutes daily
Exclusion criteria:drugs;smoking; alcohol consumption ;chronic systemic diseases;truma; xerostomia;history of head and neck radiotherapy and chemotherapy;people under 18 years;using nutritional supplements;periodontal diseases;using handsfree
Age
No age limit
Gender
Both
Phase
4
Groups that have been masked
No information
Sample size
Target sample size:
30
Randomization (investigator's opinion)
N/A
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Single
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Zahedan University of Medical Sciences